Saeed Sadeghi, MD, discusses the findings on transfusion independence achieved with treatment for patients with low-risk myelodysplastic syndrome.

Swedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals ...

Open label study in forty AML and MDS patients Study financed by the US Department of Defense Cantargia (Cantargia AB; Nasdaq ...

What is Guillain-Barré syndrome? Guillain-Barré syndrome (GBS) is also called acute inflammatory demyelinating polyradiculoneuropathy (AIDP). It's a neurological disorder in which the body's immune ...

TScan Therapeutics is developing TSC-101 and multiplex TCR-Ts for cancer treatment. See why TCRX stock holds potential with ...

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and ...

Keros’ most advanced product candidate, elritercept (KER-050), is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with ...

Fanconi anemia (FA) is a rare genetic disorder impairing bone marrow's blood cell production, leading to severe health issues. Early diagnosis and tre ...

Staphylococcal scalded skin syndrome (SSSS), also known as Ritter's disease, is a serious skin condition caused by certain strains of Staphylococcus aureus (S. aureus) bacteria. It causes large, ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. For many shoppers, Amazon Prime is a no-brainer for the shipping perks alone. However ...

What Is Burning Mouth Syndrome? Burning mouth syndrome (BMS) is the name for burning pain in your mouth that doesn't have a known cause. Most often, the pain is on the tip of your tongue or roof ...